The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% As scientific and technological advancements ...
Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against variola virus, the causative agent of smallpox, and has therefore been ...
Explore a comprehensive guide to standardizing large scale production and clarification of lentiviral vectors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback